[ad_1]
A recent report released by the Cybersecurity and Infrastructure Security Agency, part of the Department of Homeland Security, finds that the FBI and the Department of Health and Human Services have credible information on a growing and imminent threat of cybercrime for hospitals and operators. US health.
MIAMI, November 9, 2020 (GLOBE NEWSWIRE) – Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a digital therapy provider providing evidence-based therapeutic interventions to healthcare patients, today announced that it has signed a partnership with BurstIQ to distribute its Ehave Dashboard on BurstIQ’s blockchain network to major healthcare organizations in the United States.
Ehave Dashboard is a data-driven platform that has been strategically developed to provide better communication between physicians and healthcare professionals. The cloud-based platform can provide critical functionality and capabilities to healthcare professionals, while enabling seamless integrations with everything from electronic health records (EHR) to telemedicine providers. Aggregating data and information into a single application has proven effective in streamlining the healthcare process for both patients and providers. As a result of the strategic partnership with BurstIQ to further develop its platform’s blockchain capabilities, Ehave Dashboard has the ability to segment data on-chain, which will enable developers, doctors, researchers, doctors, hospitals, universities and ultimately prescribers. of psychedelic therapy, to provide life-changing solutions to patients.
The Ehave Dashboard was developed over years of testing with mental health professionals at one of Canada’s largest hospitals, The Hospital for Sick Children in Ontario. In addition to providing better results, the proprietary platform allows people to take control of their physical and mental health by allowing them to take their medical records with them wherever they go. BurstIQ is a HIPAA and GDPR compliant global data platform and the industry’s only big data blockchain that keeps data on-chain and secure in the cloud.
Protecting patient data and electronic health records is of the utmost importance to healthcare professionals. The US Cybersecurity and Infrastructure Security Agency (CISA), with the Federal Bureau of Investigation and the Department of Health and Human Services, have issued a cybersecurity advisory to the US healthcare sector regarding a concerted effort to compromise and take hostage computer systems of health care providers.I Several healthcare companies have been hit by litigation due to compromised patient medical records. The Civil Rights Office reached an agreement with the city of New Haven, Connecticut that included a civil fine of $ 202,400 and a corrective action plan, following a breach of protected health information of only 498 patients caused by a 2017 HIPAA violation.ii Patients whose medical records have been accessed improperly by a former Mayo Clinic employee are attempting to file a lawsuit against the health care provider for failing to protect their sensitive personal data.iii Riverside Psychiatric Medical Group agrees with HHS OCR to resolve a potential violation of the HIPAA right of access. Missouri-based Saint Francis Healthcare System has reached a resolution of a $ 350,000 lawsuit with patients affected by a ransomware attack against Ferguson Medical Group.iv These are just a few examples of the seriousness of protecting electronic health records.
“Through the use of advanced technologies, such as cloud computing, analytics, machine learning and artificial intelligence, medical professionals and researchers are building an ecosystem that can enable better patient diagnostics, treatment and monitoring services from remote, “said Ben Kaplan, President and CEO of Ehave, Inc.” Together, Ehave and BurstIQ can help significantly reduce unnecessary and costly procedures, while improving patient satisfaction and outcomes. “
On September 22, 2020, Ehave, Inc. said in a press release that its wholly owned subsidiary, Mycotopia Therapy, would act as a booking site for two partner pickup centers. Ehave will not offer Jamaica-based pickup via www.mycomeditations.com. Ehave continues to explore other options in the area.
Additional Statement by Ehave Inc.
We are truly grateful for the patience and support of EHVVF shareholders! Join the conversation about our Ehave supporter’s Telegram group at https://t.me/EhaveInc.
The company diligently publishes important information and updates via weekly videos from the company’s official YouTube channel https://www.youtube.com/channel/UCnyW1mgMd0qmYkEMq3O6FWA.
About Ehave, Inc.
Ehave, Inc. (EHVVF) is a digital therapy provider that provides patients with evidence-based therapeutic interventions. Our primary goal is to improve standard of care in therapies to prevent or treat brain disorders or diseases through the use of digital therapies, independently or in combination, with drugs, devices and other therapies to optimize patient care and health outcomes. Our core product is Ehave Telemetry Portal, a mental health information platform that enables clinicians to make objective and intelligent decisions through knowledge of data. The Ehave Infinity Portal offers a powerful machine learning and artificial intelligence platform with a growing set of advanced tools and applications developed by Ehave and its key partners. This enables patients, healthcare professionals and payers to address a wide range of conditions through high quality, safe and effective data-driven engagement with intelligent and accessible tools. For more information visit: www.ehave.com.
About Medchart
Medchart digitizes the exchange of health information between healthcare professionals, lawyers, insurers, payers, researchers and patients by improving the speed of transfer, data quality and business information through artificial intelligence and machine learning. The company provides cloud-based medical record solutions across North America with specially designed solutions for mass personal injury and lawyers in the United States.
Future Disclaimer
This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may be preceded by the words “intends”, “may”, “will”, “plan”, “expect,” “anticipate” , “projects”, “predicts”, “estimates”, “goals”, “believes”, “hopes”, “potential” or similar words. Forward-looking statements are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company’s control and cannot be predicted or quantified and, as a result, actual results may differ materially from those expressed or implied by such forward-looking statements: (i) the commencement, timing, progress and results of the Company’s research, production and other development activities; (ii) the Company’s ability to promote its products to successfully complete development and marketing; (iii) the production, development, marketing and market acceptance of the Company’s products; (iv) the lack of sufficient funds to finance product development and commercial operations; (v) competitive companies and technologies in the Company’s sector and introduction of competing products; (vi) the Company’s ability to establish and maintain business partnerships; (vii) loss of executives with strategic responsibilities; (viii) the scope of protection that the Company is able to establish and maintain for the intellectual property rights that cover its products and its ability to carry out its business without infringing the intellectual property rights of others; (ix) potential failure to comply with applicable health information security and privacy laws and other state and federal privacy and security laws; and (x) the difficulty of predicting the actions of the US FDA and its regulations. All forward-looking statements included in this press release are made only as of the date of this press release. The Company undertakes no obligation to update any written or oral forward-looking statements unless required by law. More detailed information about the Company and the risk factors that may affect the making of forward-looking statements is contained in the “Risk Factors” section of the Ehave, Inc. Registration Statement on Form F-1 filed with the Securities and Exchange Commission (SEC ) on September 24, 2015, as amended, available on the SEC website, http://www.sec.gov.
For investor relations, please contact:
Gabe Rodriguez
Phone: (623) 261-9046
Email: [email protected]
_________________________
I https://securityboulevard.com/2020/11/us-health-care-under-attack/
ii https://healthitsecurity.com/news/new-haven-pays-ocr-202k-for-phi-breach-of-498-patients-hipaa-failure
iii https://www.databreaches.net/mayo-clinic-faces-lawsuit-in-breach-of-patients-health-records/
iv https://healthitsecurity.com/news/ocr-settles-with-psychiatric-provider-for-hipaa-right-of-access-violation
.[ad_2]Source link
